Plasma levels of endogenous hydrogen sulfide and homocysteine in patients with Alzheimer's disease and vascular dementia and the significance thereof

National Medical Journal of China

Volumn 88, Issue 32, 2008, Pages 2246-2249

  Liu, Xiang Qin ^a   Liu, Xiao Qi ^b   Jiang, Ping ^b   Huang, Hua ^b   Yan, Yong ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Alzheimer disease; Dementia, vascular; Homocysteine; Hydrogen sulfide

Indexed keywords

HOMOCYSTEINE; HYDROGEN SULFIDE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DAILY LIFE ACTIVITY; DISEASE SEVERITY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; PATHOGENESIS; PROTEIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DEMENTIA, VASCULAR; FEMALE; HOMOCYSTEINE; HUMANS; HYDROGEN SULFIDE; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES;

EID: 54949132099     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Takashi K, Kazunori I, Hitoshi T. Are cerebrovascular factors involved in Alzheimer's disease. Neurobiol Aging, 2001, 21: 1215-1224.
2. Kalaria RN. The role cerebral ischemia in Alzheimer's disease. Neurobiol Aging, 2000, 21:321-330.
3. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 1984, 34:939-944.
4. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology, 1993, 43: 250-260.
5. Chinese source.
6. Eto K, Asada T, Arima K, et al. Brain hydrogen sulfide is severely decreased in Alzheimer's disease. Biochem Biophys Res Commun, 2002, 293: 1485-1488.
7. Chinese source.
8. Whiteman M, Armstrong JS, Chu SH, et al. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite "scavenger"? Neurochem, 2004, 90:765-768.
9. Wang R. The gasotransmitter role of hydrogen sulfide. Antioxid Redox Signal, 2003, 5:493-501.
10. Kimura Y, Kimura H. Hydrogen sulfide protects neurons from oxidative stress. Faseb, 2004, 18:1165-1167.
11. Whiteman M, Cheung NC, Zhu YZ, et al. Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain? Biochem Biophys Res Commun, 2005, 326:794-798.
12. Kimura Y, Kimura H. Physiological roles of hydrogen sulfide: synaptic modulation, neuroprotection, and smooth muscle relaxation. Antioxid Redox Signal, 2005, 7:795-803.
13. Obeid R, Herrmann W. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett, 2006, 580:2994-3005.
14. Joosten E. Homocysteine, vascular dementia and Alzheimer's disease. Clin Chem Lab Med, 2001,39:717-720.
15. Ravaqlia G, Forti P, Maioli F, et al. Blood inflammatory markers and risk of dementia: The Conselice Study of Brain Aging. Neurobiol Aging, 2007, 28: 1810-1820.
16. Sachdev PS, Brodaty H, Valenzula MJ, et al. Clinical determinants of dementia and mild cognitive impairment following ischaemic stroke: the Sydney Stroke Study. Dement Geriatr Cogn Disord, 2006, 21:275-283.
17. Lawrence de Koning AB, Werstuck GH, Zhou J, et al. Hyperhomocysteinemia and its role in the development of atherosclerosis. Clin Biochem, 2003, 36:431-441.
18. Hassan A, Hunt BJ, O'Sulliuan M, et al. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain, 2004, 127(Pt 1):212-219.
19. Briani C, Cagnin A, Gallo L, et al. Anti-heparan sulphate antibodies and homocysteine in dementia: markers of vascular pathology? J Neurol Sci, 2005, 229-230:215-218.
20. Boxer AL, Kramer JH, Johnston K, et al. Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment. Neurology, 2005, 64:1431-1434.
21. Chinese source.